Stockholders' Equity - Schedule of Common Stock Warrant Activity (Details) - Common Stock Warrants $ / shares in Units, $ in Thousands |
12 Months Ended |
|---|---|
|
Dec. 31, 2022
USD ($)
$ / shares
shares
| |
| Shares | |
| Outstanding at beginning (in shares) | shares | 668,907 |
| Exercised (in shares) | shares | (462,353) |
| Terminated (in shares) | shares | (170,000) |
| Outstanding at ending (in shares) | shares | 36,554 |
| Weighted - Average Exercise Price | |
| Outstanding at beginning (in usd per share) | $ / shares | $ 2.97 |
| Exercised (in usd per share) | $ / shares | 2.20 |
| Terminated (in usd per share) | $ / shares | 2.20 |
| Outstanding at ending (in usd per share) | $ / shares | 16.23 |
| Outstanding Warrants | |
| Exercise Price | $ / shares | $ 16.23 |
| Number Outstanding | shares | 36,554 |
| Weighted-Average Remaining Contractual Life | 5 months 15 days |
| Intrinsic value | $ | $ 0 |
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the other than stock option plan. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the other than stock option plan. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to other than stock options that were terminated. No definition available.
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|